Cargando…
Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions
Biguanides, particularly the widely prescribed drug metformin, have been marketed for many decades and have well-established absorption profiles. They are commonly administered via the oral route and, despite variation in oral uptake, remain commonly prescribed for diabetes mellitus, typically type...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775521/ https://www.ncbi.nlm.nih.gov/pubmed/35055022 http://dx.doi.org/10.3390/ijms23020836 |
_version_ | 1784636606036049920 |
---|---|
author | Jones, Melissa Ionescu, Corina Mihaela Walker, Daniel Wagle, Susbin Raj Kovacevic, Bozica Chester, Jacqueline Foster, Thomas Johnston, Edan Kuthubutheen, Jafri Brown, Daniel Atlas, Marcus D. Mikov, Momir Mooranian, Armin Al-Salami, Hani |
author_facet | Jones, Melissa Ionescu, Corina Mihaela Walker, Daniel Wagle, Susbin Raj Kovacevic, Bozica Chester, Jacqueline Foster, Thomas Johnston, Edan Kuthubutheen, Jafri Brown, Daniel Atlas, Marcus D. Mikov, Momir Mooranian, Armin Al-Salami, Hani |
author_sort | Jones, Melissa |
collection | PubMed |
description | Biguanides, particularly the widely prescribed drug metformin, have been marketed for many decades and have well-established absorption profiles. They are commonly administered via the oral route and, despite variation in oral uptake, remain commonly prescribed for diabetes mellitus, typically type 2. Studies over the last decade have focused on the design and development of advanced oral delivery dosage forms using bio nano technologies and novel drug carrier systems. Such studies have demonstrated significantly enhanced delivery and safety of biguanides using nanocapsules. Enhanced delivery and safety have widened the potential applications of biguanides not only in diabetes but also in other disorders. Hence, this review aimed to explore biguanides’ pharmacokinetics, pharmacodynamics, and pharmaceutical applications in diabetes, as well as in other disorders. |
format | Online Article Text |
id | pubmed-8775521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87755212022-01-21 Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions Jones, Melissa Ionescu, Corina Mihaela Walker, Daniel Wagle, Susbin Raj Kovacevic, Bozica Chester, Jacqueline Foster, Thomas Johnston, Edan Kuthubutheen, Jafri Brown, Daniel Atlas, Marcus D. Mikov, Momir Mooranian, Armin Al-Salami, Hani Int J Mol Sci Review Biguanides, particularly the widely prescribed drug metformin, have been marketed for many decades and have well-established absorption profiles. They are commonly administered via the oral route and, despite variation in oral uptake, remain commonly prescribed for diabetes mellitus, typically type 2. Studies over the last decade have focused on the design and development of advanced oral delivery dosage forms using bio nano technologies and novel drug carrier systems. Such studies have demonstrated significantly enhanced delivery and safety of biguanides using nanocapsules. Enhanced delivery and safety have widened the potential applications of biguanides not only in diabetes but also in other disorders. Hence, this review aimed to explore biguanides’ pharmacokinetics, pharmacodynamics, and pharmaceutical applications in diabetes, as well as in other disorders. MDPI 2022-01-13 /pmc/articles/PMC8775521/ /pubmed/35055022 http://dx.doi.org/10.3390/ijms23020836 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Jones, Melissa Ionescu, Corina Mihaela Walker, Daniel Wagle, Susbin Raj Kovacevic, Bozica Chester, Jacqueline Foster, Thomas Johnston, Edan Kuthubutheen, Jafri Brown, Daniel Atlas, Marcus D. Mikov, Momir Mooranian, Armin Al-Salami, Hani Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions |
title | Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions |
title_full | Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions |
title_fullStr | Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions |
title_full_unstemmed | Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions |
title_short | Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions |
title_sort | biguanide pharmaceutical formulations and the applications of bile acid-based nano delivery in chronic medical conditions |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775521/ https://www.ncbi.nlm.nih.gov/pubmed/35055022 http://dx.doi.org/10.3390/ijms23020836 |
work_keys_str_mv | AT jonesmelissa biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT ionescucorinamihaela biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT walkerdaniel biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT waglesusbinraj biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT kovacevicbozica biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT chesterjacqueline biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT fosterthomas biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT johnstonedan biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT kuthubutheenjafri biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT browndaniel biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT atlasmarcusd biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT mikovmomir biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT mooranianarmin biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions AT alsalamihani biguanidepharmaceuticalformulationsandtheapplicationsofbileacidbasednanodeliveryinchronicmedicalconditions |